International Flavors & Fragrances Indefinite-Lived Research and Development Assets increased by 8.4% to $167.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.4%, from $154.00M to $167.00M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 41.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $42.00M | $84.00M | $125.00M | $154.00M | $167.00M |
| QoQ Change | — | +100.0% | +48.8% | +23.2% | +8.4% |
| YoY Change | — | +100.0% | +48.8% | +23.2% | +8.4% |